https://www.selleckchem.com/pr....oducts/semaxanib-su5
Aim We retrospectively evaluated the role of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) as prognostic factors in metastatic non-small-cell lung cancer patients treated with nivolumab. Materials methods Medical records of 65 patients were reviewed. NLR and LMR were calculated at baseline (t and at first radiological tumor assessment (t1). Results At univariate analysis, low NLR or high LMR values at t0 were associated with longer overall survival (p = 0.0001). At multivariate analysis inc
Like
Comment
Share
